Alcon is a pharmaceutical company that specializes in eye care products, including surgical equipment, contact lenses and solutions, eye drops and ointments, and intraocular lenses.
Alcon was founded in Fort Worth, Texas in 1945.
In 1977, Alcon became a publicly traded company.
In 2010, Alcon was acquired by Novartis and became a division of the company.
In 2019, Novartis announced plans to spin off Alcon into a separate publicly traded company.
In April 2019, Alcon became an independent company and began trading on the Swiss stock exchange.
A division of Johnson & Johnson that produces contact lenses, surgical equipment, and eye drops.
A subsidiary of Bausch Health Companies that produces contact lenses, eye drops, and ointments.
A subsidiary of The Cooper Companies that produces contact lenses.
Daily disposable contact lenses that provide moisture and comfort to the eyes.
Eye drops that provide long-lasting relief of dry eye symptoms.
Lenses that are implanted in the eye during cataract surgery to replace the eye's natural lens.
Alcon is known for its eye care products, including surgical equipment, contact lenses and solutions, eye drops and ointments, and intraocular lenses.
Yes, Alcon became a publicly traded company in 1977. However, it was acquired by Novartis in 2010 and became a division of the company until 2019 when it became an independent company.
Some of Alcon's most popular products include DAILIES AquaComfort Plus contact lenses, SYSTANE ULTRA lubricant eye drops, and AcrySof IQ intraocular lenses.
Alcon's competitors include Johnson & Johnson Vision, Bausch + Lomb, and CooperVision.
Alcon was acquired by Novartis in 2010 and became a division of the company until 2019 when it became an independent company through a spin-off.